Optimized Sampling Conditions for Fecal Volatile Organic Compound Analysis by Means of Field Asymmetric Ion Mobility Spectrometry

Fecal volatile organic compounds (VOCs) are increasingly considered to be potential noninvasive, diagnostic biomarkers for various gastrointestinal diseases. Knowledge of the influence of sampling conditions on VOC outcomes is limited. We aimed to evaluate the effects of sampling conditions on fecal VOC profiles and to assess under which conditions an optimal diagnostic accuracy in the discrimination between pediatric inflammatory bowel disease (IBD) and controls could be obtained. Fecal samples from de novo treatment-naïve pediatric IBD patients and healthy controls (HC) were used to assess the effects of sampling conditions compared to the standard operating procedure (reference standard), defined as 500 mg of sample mass diluted with 10 mL tap water, using field asymmetric ion mobility spectrometry (FAIMS). A total of 17 IBD (15 CD (Crohn's disease) and 2 UC (ulcerative colitis)) and 25 HC were included. IBD and HC could be discriminated with high accuracy (accuracy = 0.93, AUC = 0.99, p < 0.0001). A smaller fecal sample mass resulted in a decreased diagnostic accuracy (300 mg accuracy = 0.77, AUC = 0.69, p = 0.02; 100 mg accuracy = 0.70, AUC = 0.74, p = 0.003). A loss of diagnostic accuracy was seen toward increased numbers of thaw–freeze cycles (one cycle, accuracy = 0.61, AUC = 0.80, p = 0.0004; two cycles, accuracy = 0.64, AUC = 0.56, p = 0.753; and three cycles, accuracy = 0.57, AUC = 0.50, p = 0.5101) and when samples were kept at room temperature for 180 min prior to analysis (accuracy = 0.60, AUC = 0.51, p = 0.46). Diagnostic accuracy of VOC profiles was not significantly influenced by storage duration differences of 20 months. The application of a 500 mg sample mass analyzed after one thaw–freeze cycle showed the best discriminative accuracy for the differentiation of IBD and HC. VOC profiles and diagnostic accuracy were significantly affected by sampling conditions, underlining the need for the implementation of standardized protocols in fecal VOC analysis.

[1]  Ó. O’Sullivan,et al.  The Effects of Freezing on Faecal Microbiota as Determined Using MiSeq Sequencing and Culture-Based Investigations , 2015, PloS one.

[2]  Tsuyoshi Murata,et al.  {m , 1934, ACML.

[3]  Elaine Holmes,et al.  Optimized Sample Handling Strategy for Metabolic Profiling of Human Feces. , 2016, Analytical chemistry.

[4]  J. Covington,et al.  Noninvasive Diagnosis of Pancreatic Cancer Through Detection of Volatile Organic Compounds in Urine. , 2017, Gastroenterology.

[5]  J. Covington,et al.  Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study. , 2018, Inflammatory bowel diseases.

[6]  H. Haick,et al.  Hybrid volatolomics and disease detection. , 2015, Angewandte Chemie.

[7]  James A. Covington,et al.  The Detection of Patients at Risk of Gastrointestinal Toxicity during Pelvic Radiotherapy by Electronic Nose and FAIMS: A Pilot Study , 2012, Sensors.

[8]  John C. Cancilla,et al.  Programmed Nanoparticles for Tailoring the Detection of Inflammatory Bowel Diseases and Irritable Bowel Syndrome Disease via Breathprint , 2016, Advanced healthcare materials.

[9]  C. Probert.  Role of faecal gas analysis for the diagnosis of IBD. , 2011, Biochemical Society transactions.

[10]  Marc A Benninga,et al.  Faecal gas analysis by electronic nose as novel, non-invasive method for assessment of active and quiescent paediatric inflammatory bowel disease: Proof of principle study. , 2014, Journal of Crohn's & colitis.

[11]  K. Perrault,et al.  Effect of age and storage conditions on the volatile organic compound profile of blood , 2014, Forensic Science, Medicine, and Pathology.

[12]  Nanne K. H. de Boer,et al.  Effects of Sampling Conditions and Environmental Factors on Fecal Volatile Organic Compound Analysis by an Electronic Nose Device , 2016, Sensors.

[13]  C. Probert,et al.  Fecal volatile organic compounds: a novel, cheaper method of diagnosing inflammatory bowel disease? , 2014, Expert review of clinical immunology.

[14]  David C Wilson,et al.  Pediatric modification of the Montreal classification for inflammatory bowel disease: The Paris classification , 2011, Inflammatory bowel diseases.

[15]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[16]  Chris Mulder,et al.  Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease , 2017, Journal of breath research.

[17]  Zlatan Mujagic,et al.  Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohn's Disease: A Metabolomic Approach , 2015, Inflammatory bowel diseases.

[18]  B. Costello,et al.  Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease , 2016, Alimentary pharmacology & therapeutics.

[19]  Richard S. Savage,et al.  Video of the Month , 2015, The American Journal of Gastroenterology.

[20]  Thomas de Quincey.  [C] , 2000, The Works of Thomas De Quincey, Vol. 1: Writings, 1799–1820.

[21]  Kenneth K Wang,et al.  Diagnosing gastrointestinal illnesses using fecal headspace volatile organic compounds. , 2016, World journal of gastroenterology.

[22]  Ramesh P Arasaradnam,et al.  Non-invasive exhaled volatile organic biomarker analysis to detect inflammatory bowel disease (IBD). , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[23]  Daniel J. C. Berkhout,et al.  Development of severe bronchopulmonary dysplasia is associated with alterations in fecal volatile organic compounds , 2018, Pediatric Research.

[24]  H. Haick,et al.  Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules , 2016, ACS nano.

[25]  A Smolinska,et al.  The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis , 2017, Alimentary pharmacology & therapeutics.

[26]  A. Ewer,et al.  Optimisation of Sample Preparation for Direct SPME-GC-MS Analysis of Murine and Human Faecal Volatile Organic Compounds for Metabolomic Studies , 2014 .

[27]  J A Covington,et al.  The application of FAIMS gas analysis in medical diagnostics. , 2015, The Analyst.

[28]  J. Covington,et al.  Variation in Gas and Volatile Compound Emissions from Human Urine as It Ages, Measured by an Electronic Nose , 2016, Biosensors.

[29]  G. Theodoridis,et al.  Sample preparation optimization in fecal metabolic profiling. , 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[30]  A. Griffiths,et al.  Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. , 2007, Gastroenterology.

[31]  J T Boyle,et al.  Development and validation of a pediatric Crohn's disease activity index. , 1991, Journal of pediatric gastroenterology and nutrition.

[32]  S. Lewis,et al.  Stool form scale as a useful guide to intestinal transit time. , 1997, Scandinavian journal of gastroenterology.